# Aytu Biopharma, Inc: Form 8-K, filed Jun 25, 2026

- Company: [Aytu Biopharma, Inc](/companies/aytu.md) (CIK 1385818)
- Form: 8-K
- Filed: 2026-06-25
- Accepted by EDGAR: Jun 25, 2026, 16:31 ET
- Period: 2026-06-23
- Accession: 0001437749-26-021707
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/aytu20260624c_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/aytu20260624c_8k.htm

Filed Jun 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-021707. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.